The Purpose of this study was to determine the stability of an extemporaneously prepared intranasal formulation of midazolam for the treatment of status epileptus in dogs. An aqueous solution of midazolam (50mg/mL) was prepared by dissolving 500mg of midazolam powder in sterile water for injection containing carbopol (0.4%) and benzalkonium chloride (0.
View Article and Find Full Text PDF